{
    "id": 31222,
    "fullName": "EHMT2 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EHMT2 positive indicates the presence of the EHMT2 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 10919,
        "geneSymbol": "EHMT2",
        "terms": [
            "EHMT2",
            "BAT8",
            "C6orf30",
            "G9A",
            "GAT8",
            "KMT1C",
            "NG36"
        ]
    },
    "variant": "positive",
    "createDate": "10/09/2019",
    "updateDate": "10/09/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 18739,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, A-366 inhibited proliferation and reduced cell viability in an EHMT2-positive acute myeloid leukemia cell line in culture, and inhibited tumor growth in a cell-line xenograft model (PMID: 26147105).",
            "molecularProfile": {
                "id": 33565,
                "profileName": "EHMT2 positive"
            },
            "therapy": {
                "id": 8827,
                "therapyName": "A-366",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16422,
                    "pubMedId": 26147105,
                    "title": "The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26147105"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 18740,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, A-366 inhibited cell proliferation in an EHMT2-positive acute promyelocytic leukemia cell line in culture (PMID: 26147105).",
            "molecularProfile": {
                "id": 33565,
                "profileName": "EHMT2 positive"
            },
            "therapy": {
                "id": 8827,
                "therapyName": "A-366",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16422,
                    "pubMedId": 26147105,
                    "title": "The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26147105"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33565,
            "profileName": "EHMT2 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}